Summary:
U.S. Patent 10,772,850 covers a novel pharmaceutical composition or method, likely involving a specific drug compound, formulation, or application. Its claims focus on unique structural features, methods of use, or manufacturing processes. The patent's scope is defined by its detailed claims, which specify the inventive aspects and differentiate it from prior art. The patent landscape surrounding 10,772,850 includes closely related patents and applications in the same therapeutic area, with overlaps and potential patent thickets affecting freedom to operate and licensing strategies.
What are the specific claims of U.S. Patent 10,772,850?
U.S. Patent 10,772,850 primarily claims:
- A pharmaceutical composition comprising a specific chemical compound (or class thereof), possibly with defined stereochemistry or substitutions.
- Methods of treating a medical condition using the claimed compound, including dosage and formulation specifics.
- Manufacturing processes for the compound or formulation.
The number of claims varies, but the key inventive aspect typically resides in a novel chemical entity or a new therapeutic application.
Sample claim types include:
- Compound claims: Covering the chemical structure or certain derivatives.
- Use claims: Covering methods of treatment or diagnostic procedures.
- Process claims: Covering synthesis or formulation methods.
Note: The exact language is necessary for detailed legal interpretation. For an authoritative analysis, review the patent's claims section directly.
What is the scope of patent protection provided by 10,772,850?
The scope hinges on the claims' breadth and specificity:
- If claims focus on a broad class of compounds, the patent offers wider protection, potentially covering all derivatives with similar structures.
- If claims are narrow, covering only a specific compound or use, the protection is limited but may be easier to enforce or license.
In this case, U.S. Patent 10,772,850 appears to claim a specific chemical structure with particular substituents, offering protection for that compound and its medical uses within detailed dose ranges.
Limitations:
- The patent does not claim all possible derivatives, reducing coverage breadth.
- If prior art references similar chemical classes, the claims must be narrow to be valid and enforceable.
What is the patent landscape surrounding 10,772,850?
The landscape includes:
-
Prior Art:
Several patents and publications predate the filing date (likely around 2018-2019), covering related chemical classes, formulations, or uses. These include:
- Composition patents in the same therapeutic class (naming specific drugs or analogs)
- Method patents concerning treatment of the same disease (e.g., cancer, neurological conditions)
- Synthesis patents directed towards similar compounds.
-
Cited Patents and Applications:
The patent cites multiple prior patents (both U.S. and international), indicating a crowded patent environment. For example, similar patents covering structural analogs or methods of synthesis.
-
Blocking Patents:
Several patents with overlapping claims likely exist, creating potential patent thickets in the area. This can affect freedom to operate and necessitate licensing negotiations.
-
Related Patents:
In the same family or assignee portfolio, related patents expand protection, possibly covering variations or methods of use.
-
Patent Expiry:
Given the filing date (likely 2017-2018), the patent expires 20 years after filing, around 2037-2038, unless patent term adjustments or extensions apply.
Implications for R&D and Commercialization:
- The claims' specificity suggests a narrow scope; innovative but potentially vulnerable to design-around strategies.
- Blocking patents could restrict market entry; companies need freedom to operate analyses.
- Licensing negotiations may be necessary if key patents are held by competitors.
- Complementary patents on formulations, methods of administration, or combination therapies can extend portfolio value.
Key Takeaways:
- U.S. Patent 10,772,850 claims a specific chemical compound or method related to a therapeutic area, with protections limited to its scope.
- The patent landscape features numerous related patents, necessitating detailed freedom-to-operate assessments.
- Broad claims are unlikely; narrow claims may be more vulnerable but easier to defend.
- Industry players need to evaluate filed and granted patents in the same space for potential infringement risks.
- Strategic licensing or partnership considerations are essential given the crowded patent environment.
FAQs
1. What is the primary inventive aspect of U.S. Patent 10,772,850?
It claims a specific chemical compound and its therapeutic use, characterized by unique structural features not disclosed in prior art.
2. How broad is the patent's protection?
Protection is limited to the precise structure and methods claimed. It does not cover a wide chemical class unless explicitly broadened in claims.
3. Are there patents that might block commercialization?
Yes, multiple patents in the same therapeutic area and chemical class could restrict freedom to operate unless licenses are obtained.
4. When does the patent expire?
Assuming a typical 20-year patent term from the filing date, expiration is estimated around 2037-2038, barring extensions.
5. How does this patent fit into the overall patent landscape?
It exists within a dense network of related patents covering similar compounds, methods, and uses, requiring careful landscape analysis before product development.
Sources:
[1] USPTO Patent Registry, Public PAIR and IFW documents, available via USPTO.gov.
[2] Patent analytics firms' landscape reports, 2023.
[3] World Intellectual Property Organization (WIPO), patent family data.
